Get the Stockscreener App
32.99
0.55%
0.179
Columbia Research Enhanced Value Etf Stock (REVS) Forecast
The Columbia Research Enhanced Value Etf (REVS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $34.51, representing a +4.59% increase from the current price of $32.99. The highest analyst price target is $35.15, and the lowest is $33.86.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month REVS Price Target
Average 36.53
(+10.72% Upside)
Is Columbia Research Enhanced Value Etf (REVS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.00 | Neutral |
| STOCH(9,6) | 15.44 | Buy |
| STOCHRSI(14) | 1.456 | Buy |
| MACD(12,26) | -0.2137 | Sell |
| ADX(14) | 59.60 | Sell |
| William %R | -86.34 | Buy |
| CCI(14) | -129.79 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
33.16
Sell
|
33.13
Sell
|
| MA20 |
33.48
Sell
|
33.35
Sell
|
| MA50 |
33.62
Sell
|
33.30
Sell
|
| MA100 |
32.68
Buy
|
32.62
Buy
|
| MA200 |
30.99
Buy
|
31.27
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, REVS could be considered a Strong Sell, with 17 technical analysis indicators signaling 7 Buy signals, 9 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on REVS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36 indicates that REVS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.44 indicates that REVS is oversold. This indicates that REVS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.456 indicates that REVS is oversold. This suggests that REVS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 59.6 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -129.79 indicates that REVS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term REVS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Columbia Research Enhanced Value Etf financial reports and earnings history, Columbia Research Enhanced Value Etf (REVS) stock could reach $47.53 by 2030, $95.17 by 2040 and $131.77 by 2050. See the projected annual prices until 2050 of the Columbia Research Enhanced Value Etf stock below:
- Columbia Research Enhanced Value Etf (REVS) is expected to reach an average price of $70.33 in 2035, with a high prediction of $70.44 and a low estimate of $68.98. This indicates an $113.17% rise from the last recorded price of $32.99.
- Columbia Research Enhanced Value Etf (REVS) stock is projected to chart a bullish course in 2040, with an average price target of $94.97, representing an $187.87% surge from its current level. The forecast ranges from a conservative $93.34 to a sky-high $95.17.
- Our analysts predict Columbia Research Enhanced Value Etf (REVS) to jump 225.55% by 2045, soaring from $106.66 to an average price of $107.40, potentially reaching $118.54. While $106.66 is the low estimate, the potential upside is significant.
- Columbia Research Enhanced Value Etf (REVS) stock is expected to climb by 2050, reaching an average of $131.74, a $299.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $131.77 and $129.47, respectively, highlighting the market's uncertainty.
Columbia Research Enhanced Value Etf Stock (REVS) Year by Year Forecast
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2026
The predicted value for Columbia Research Enhanced Value Etf (REVS) in 2026 is set at an average of $33.32. Estimates vary from a peak of $36.47 to a trough of $30.17, indicating an +1.01% surge from the present price of $32.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $35.06 | $33.86 | $35.15 | +6.28% |
| December, 2026 | $36.14 | $35.06 | $36.47 | +9.56% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Columbia Research Enhanced Value Etf (REVS) is $36.53, with a high forecast of $39.60 and a low forecast of $33.45. This indicates an +10.72% increase from the last price of $32.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $35.58 | $35.15 | $36.26 | +7.85% |
| February, 2027 | $34.00 | $33.85 | $35.86 | +3.06% |
| March, 2027 | $35.11 | $33.45 | $35.21 | +6.43% |
| April, 2027 | $35.84 | $35.09 | $35.85 | +8.64% |
| May, 2027 | $36.52 | $35.98 | $36.86 | +10.69% |
| June, 2027 | $37.14 | $36.14 | $37.26 | +12.57% |
| July, 2027 | $37.99 | $36.90 | $38.03 | +15.16% |
| August, 2027 | $39.09 | $38.06 | $39.30 | +18.50% |
| September, 2027 | $38.95 | $38.30 | $39.60 | +18.06% |
| October, 2027 | $37.12 | $36.65 | $39.10 | +12.53% |
| November, 2027 | $37.51 | $36.29 | $37.56 | +13.70% |
| December, 2027 | $38.66 | $37.19 | $38.69 | +17.19% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2028
In 2028, Columbia Research Enhanced Value Etf (REVS) is projected to reach an average price of $41.64, with a high projection of $44.78 and a low estimate of $38.51. This indicates an +26.23% rise from the last price of $32.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $39.36 | $38.51 | $39.79 | +19.31% |
| February, 2028 | $39.91 | $39.13 | $39.94 | +20.99% |
| March, 2028 | $40.89 | $39.93 | $41.00 | +23.94% |
| April, 2028 | $41.66 | $40.87 | $41.94 | +26.28% |
| May, 2028 | $41.70 | $41.44 | $42.72 | +26.40% |
| June, 2028 | $39.67 | $39.45 | $42.28 | +20.25% |
| July, 2028 | $39.51 | $39.12 | $40.38 | +19.75% |
| August, 2028 | $41.27 | $39.64 | $41.27 | +25.10% |
| September, 2028 | $42.16 | $41.36 | $42.72 | +27.81% |
| October, 2028 | $42.40 | $42.11 | $42.64 | +28.53% |
| November, 2028 | $43.47 | $42.47 | $43.60 | +31.76% |
| December, 2028 | $44.62 | $43.42 | $44.78 | +35.26% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2029
The 2029 price forecast for Columbia Research Enhanced Value Etf Stock (REVS) is $45.46 on average, with a high prediction of $48.98 and a low estimate of $41.95. This represents an +37.81% increase from the previous price of $32.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $44.88 | $44.60 | $45.85 | +36.05% |
| February, 2029 | $45.02 | $44.59 | $45.44 | +36.46% |
| March, 2029 | $41.97 | $41.95 | $43.21 | +27.22% |
| April, 2029 | $43.74 | $42.09 | $43.83 | +32.58% |
| May, 2029 | $45.44 | $43.75 | $45.65 | +37.74% |
| June, 2029 | $45.44 | $44.87 | $45.62 | +37.74% |
| July, 2029 | $46.19 | $45.10 | $46.31 | +40.01% |
| August, 2029 | $47.35 | $45.98 | $47.43 | +43.52% |
| September, 2029 | $48.89 | $47.39 | $48.90 | +48.20% |
| October, 2029 | $48.26 | $47.74 | $48.98 | +46.27% |
| November, 2029 | $45.29 | $45.05 | $48.58 | +37.27% |
| December, 2029 | $46.03 | $44.78 | $46.11 | +39.53% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2030
Columbia Research Enhanced Value Etf Stock (REVS) is expected to reach an average price of $49.39 in 2030, with a high forecast of $52.72 and a low forecast of $46.07. This signifies an +49.72% surge from the last price of $32.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $47.52 | $46.07 | $47.53 | +44.04% |
| February, 2030 | $48.37 | $47.70 | $48.58 | +46.62% |
| March, 2030 | $49.01 | $48.08 | $49.28 | +48.55% |
| April, 2030 | $50.04 | $49.01 | $50.15 | +51.68% |
| May, 2030 | $51.51 | $50.06 | $51.72 | +56.14% |
| June, 2030 | $51.14 | $50.89 | $52.10 | +55.02% |
| July, 2030 | $48.37 | $47.85 | $51.78 | +46.61% |
| August, 2030 | $48.93 | $47.62 | $48.93 | +48.31% |
| September, 2030 | $49.96 | $48.65 | $49.96 | +51.45% |
| October, 2030 | $51.17 | $50.09 | $51.51 | +55.11% |
| November, 2030 | $51.90 | $51.07 | $51.92 | +57.31% |
| December, 2030 | $52.58 | $51.95 | $52.72 | +59.39% |
1.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):